• 1. Wolff CA, Holmes SP, Young BD, et al. Magnetic resonance imaging for the differentiation of neoplastic, inflammatory, and cerebrovascular brain disease in dogs. J Vet Intern Med 2012; 26: 589597.

    • Search Google Scholar
    • Export Citation
  • 2. Leclerc MK, d'Anjou MA, Blond L, et al. Interobserver agreement and diagnostic accuracy of brain magnetic resonance imaging in dogs. J Am Vet Med Assoc 2013; 242: 16881695.

    • Search Google Scholar
    • Export Citation
  • 3. Cherubini GB, Mantis P, Martinez TA, et al. Utility of magnetic resonance imaging for distinguishing neoplastic from non-neoplastic brain lesions in dogs and cats. Vet Radiol Ultrasound 2005; 46: 384387.

    • Search Google Scholar
    • Export Citation
  • 4. Young BD, Fosgate GT, Holmes SP, et al. Evaluation of standard magnetic resonance characteristics used to differentiate neoplastic, inflammatory, and vascular brain lesions in dogs. Vet Radiol Ultrasound 2014; 55: 399406.

    • Search Google Scholar
    • Export Citation
  • 5. Barker PB, Bizzi A, Stefano ND, et al. Introduction to MR spectroscopy. In: Clinical MR spectroscopy. Cambridge, England: Cambridge University Press, 2010;119.

    • Search Google Scholar
    • Export Citation
  • 6. de Graaf RA. In vivo NMR spectroscopy-static aspects. In: In vivo NMR spectroscopy: principles and techniques. 2nd ed. Chichester, West Sussex, England: John Wiley & Sons Ltd, 2007; 43111.

    • Search Google Scholar
    • Export Citation
  • 7. Provencher SW. Automatic quantitation of localized in vivo 1H spectra with LCModel. NMR Biomed 2001; 14: 260264.

  • 8. Carrera I, Richter H, Meier D, et al. Regional metabolite concentrations in the brain of healthy dogs measured by use of short echo time, single voxel proton magnetic resonance spectroscopy at 3.0 Tesla. Am J Vet Res 2015; 76: 129141.

    • Search Google Scholar
    • Export Citation
  • 9. Ono K, Kitagawa M, Ito D, et al. Regional variations and age-related changes detected with magnetic resonance spectroscopy in the brain of healthy dogs. Am J Vet Res 2014; 75: 179186.

    • Search Google Scholar
    • Export Citation
  • 10. Warrington CD, Feeney DA, Ober CP, et al. Relative metabolite concentrations and ratios determined by use of 3-T region-specific proton magnetic resonance spectroscopy of the brain of healthy Beagles. Am J Vet Res 2013; 74: 12911303.

    • Search Google Scholar
    • Export Citation
  • 11. Beckmann K, Carrera I, Steffen F, et al. A newly designed radiation therapy protocol in combination with prednisolone as treatment for meningoencephalitis of unknown origin in dogs: a prospective pilot study introducing magnetic resonance spectroscopy as monitor tool. Acta Vet Scand 2015; 57: 418.

    • Search Google Scholar
    • Export Citation
  • 12. Carrera I, Kircher PR, Meier D, et al. In vivo proton magnetic resonance spectroscopy for the evaluation of hepatic encephalopathy in dogs. Am J Vet Res 2014; 75: 818827.

    • Search Google Scholar
    • Export Citation
  • 13. Stadler KL, Ober CP, Feeney DA, et al. Multivoxel proton magnetic resonance spectroscopy of inflammatory and neoplastic lesions of the canine brain at 3.0 T. Am J Vet Res 2014; 75: 982989.

    • Search Google Scholar
    • Export Citation
  • 14. Vite CH, Cross JR. Correlating magnetic resonance findings with neuropathology and clinical signs in dogs and cats. Vet Radiol Ultrasound 2011; 52: S23S31.

    • Search Google Scholar
    • Export Citation
  • 15. Bertholdo D, Watcharakorn A, Castillo M. Brain proton magnetic resonance spectroscopy: introduction and overview. Neuroimaging Clin North Am 2013; 23: 359380.

    • Search Google Scholar
    • Export Citation
  • 16. Gill SS, Thomas DG, Van Bruggen N, et al. Proton MR spectroscopy of intracranial tumours: in vivo and in vitro studies. J Comput Assist Tomogr 1990; 14: 497504.

    • Search Google Scholar
    • Export Citation
  • 17. Law M. MR spectroscopy of brain tumors. Top Magn Reson Imaging 2004; 15: 291313.

  • 18. Negendank WG, Sauter R, Brown TR, et al. Proton magnetic resonance spectroscopy in patients with glial tumors: a multicenter study. J Neurosurg 1996; 84: 449458.

    • Search Google Scholar
    • Export Citation
  • 19. Chang L, Ernst T, Leonido-Yee M, et al. Cerebral metabolite abnormalities correlate with clinical severity of HIV-1 cognitive motor complex. Neurology 1999; 52: 100108.

    • Search Google Scholar
    • Export Citation
  • 20. Chang L, Ernst T, Leonido-Yee M, et al. Highly active antiretroviral therapy reverses brain metabolite abnormalities in mild HIV dementia. Neurology 1999; 53: 782789.

    • Search Google Scholar
    • Export Citation
  • 21. Matsumura A, Isobe T, Anno I, et al. Correlation between choline and MIB-1 index in human gliomas. A quantitative in proton MR spectroscopy study. J Clin Neurosci 2005; 12: 416420.

    • Search Google Scholar
    • Export Citation
  • 22. Isobe T, Matsumura A, Anno I, et al. Quantification of cerebral metabolites in glioma patients with proton MR spectroscopy using T2 relaxation time correction. Magn Reson Imaging 2002; 20: 343349.

    • Search Google Scholar
    • Export Citation
  • 23. Hattingen E, Raab P, Franz K, et al. Prognostic value of choline and creatine in WHO grade II gliomas. Neuroradiology 2008; 50: 759767.

    • Search Google Scholar
    • Export Citation
  • 24. Hazany S, Hesselink JR, Healy JF, et al. Utilization of glutamate/creatine ratios for proton spectroscopic diagnosis of meningiomas. Neuroradiology 2007; 49: 121127.

    • Search Google Scholar
    • Export Citation
  • 25. Dringen R, Verleysdonk S, Hamprecht B, et al. Metabolism of glycine in primary astroglial cells: synthesis of creatine, serine, and glutathione. J Neurochem 1998; 70: 835840.

    • Search Google Scholar
    • Export Citation
  • 26. Chang L, Munsaka SM, Kraft-Terry S, et al. Magnetic resonance spectroscopy to assess neuroinflammation and neuropathic pain. J Neuroimmune Pharmacol 2013; 8: 576593.

    • Search Google Scholar
    • Export Citation
  • 27. Mader I, Rauer S, Gall P, et al. (1)H MR spectroscopy of inflammation, infection and ischemia of the brain. Eur J Radiol 2008; 67: 250257.

    • Search Google Scholar
    • Export Citation
  • 28. Mader I, Roser W, Kappos L, et al. Serial proton MR spectroscopy of contrast-enhancing multiple sclerosis plaques: absolute metabolic values over 2 years during a clinical pharmacological study. AJNR Am J Neuroradiol 2000; 21: 12201227.

    • Search Google Scholar
    • Export Citation
  • 29. Moller-Hartmann W, Herminghaus S, Krings T, et al. Clinical application of proton magnetic resonance spectroscopy in the diagnosis of intracranial mass lesions. Neuroradiology 2002; 44: 371381.

    • Search Google Scholar
    • Export Citation
  • 30. Morita N, Harada M, Otsuka H, et al. Clinical application of MR spectroscopy and imaging of brain tumor. Magn Reson Med Sci 2010; 9: 167175.

    • Search Google Scholar
    • Export Citation
  • 31. Panigrahy A, Nelson MD Jr, Bluml S. Magnetic resonance spectroscopy in pediatric neuroradiology: clinical and research applications. Pediatr Radiol 2010; 40: 330.

    • Search Google Scholar
    • Export Citation
  • 32. Rossi A, Biancheri R. Magnetic resonance spectroscopy in metabolic disorders. Neuroimaging Clin North Am 2013; 23: 425448.

  • 33. Tartaglia MC, Arnold DL. The role of MRS and fMRI in multiple sclerosis. Adv Neurol 2006; 98: 185202.

  • 34. De Stefano N, Matthews PM, Arnold DL. Reversible decreases in N-acetylaspartate after acute brain injury. Magn Reson Med 1995; 34: 721727.

    • Search Google Scholar
    • Export Citation
  • 35. De Stefano N, Matthews PM, Ford B, et al. Short-term dichloroacetate treatment improves indices of cerebral metabolism in patients with mitochondrial disorders. Neurology 1995; 45: 11931198.

    • Search Google Scholar
    • Export Citation
  • 36. Sailasuta N, Ross W, Ananworanich J, et al. Change in brain magnetic resonance spectroscopy after treatment during acute HIV infection. PLoS ONE 2012; 7: e49272.

    • Search Google Scholar
    • Export Citation
  • 37. Cho YD, Choi GH, Lee SP, et al. (1)H-MRS metabolic patterns for distinguishing between meningiomas and other brain tumors. Magn Reson Imaging 2003; 21: 663672.

    • Search Google Scholar
    • Export Citation
  • 38. Demir MK, Iplikcioglu AC, Dincer A, et al. Single voxel proton MR spectroscopy findings of typical and atypical intracranial meningiomas. Eur J Radiol 2006; 60: 4855.

    • Search Google Scholar
    • Export Citation
  • 39. Opstad KS, Provencher SW, Bell BA, et al. Detection of elevated glutathione in meningiomas by quantitative in vivo 1H MRS. Magn Reson Med 2003; 49: 632637.

    • Search Google Scholar
    • Export Citation
  • 40. Opstad KS, Bell BA, Griffiths JR, et al. Taurine: a potential marker of apoptosis in gliomas. Br J Cancer 2009; 100: 789794.

  • 41. Rao GM, Rao AV, Raja A, et al. Role of antioxidant enzymes in brain tumours. Clin Chim Acta 2000; 296: 203212.

  • 42. Locigno R, Castronovo V. Reduced glutathione system: role in cancer development, prevention and treatment (review). Int J Oncol 2001; 19: 221236.

    • Search Google Scholar
    • Export Citation
  • 43. Blasel S, Pfeilschifter W, Jansen V, et al. Metabolism and regional cerebral blood volume in autoimmune inflammatory demyelinating lesions mimicking malignant gliomas. J Neurol 2011; 258: 113122.

    • Search Google Scholar
    • Export Citation
  • 44. Meyerhoff DJ, Bloomer C, Cardenas V, et al. Elevated subcortical choline metabolites in cognitively and clinically asymptomatic HIV+ patients. Neurology 1999; 52: 9951003.

    • Search Google Scholar
    • Export Citation
  • 45. Alkan A, Sarac K, Kutlu R, et al. Early- and late-state subacute sclerosing panencephalitis: chemical shift imaging and single-voxel MR spectroscopy. AJNR Am J Neuroradiol 2003; 24: 501506.

    • Search Google Scholar
    • Export Citation
  • 46. Aydin K, Tatli B, Ozkan M, et al. Quantification of neurometabolites in subacute sclerosing panencephalitis by 1H-MRS. Neurology 2006; 67: 911913.

    • Search Google Scholar
    • Export Citation
  • 47. Hattingen E, Raab P, Franz K, et al. Myo-inositol: a marker of reactive astrogliosis in glial tumors? NMR Biomed 2008; 21: 233241.

    • Search Google Scholar
    • Export Citation
  • 48. Bitsch A, Bruhn H, Vougioukas V, et al. Inflammatory CNS demyelination: histopathologic correlation with in vivo quantitative proton MR spectroscopy. AJNR Am J Neuroradiol 1999; 20: 16191627.

    • Search Google Scholar
    • Export Citation
  • 49. Gheuens S, Ngo L, Wang X, et al. Metabolic profile of PML lesions in patients with and without IRIS: an observational study. Neurology 2012; 79: 10411048.

    • Search Google Scholar
    • Export Citation
  • 50. Ozbek O, Koc O, Paksoy Y, et al. Epstein-Barr virus encephalitis: findings of MRI, MRS, diffusion and perfusion. Turk J Pediatr 2011; 53: 680683.

    • Search Google Scholar
    • Export Citation
  • 51. Wu WE, Tal A, Kirov II, et al. Global gray and white matter metabolic changes after simian immunodeficiency virus infection in CD8-depleted rhesus macaques: proton MRS imaging at 3 T. NMR Biomed 2013; 26: 480488.

    • Search Google Scholar
    • Export Citation
  • 52. Brand A, Leibfritz D, Richter-Landsberg C. Oxidative stress-induced metabolic alterations in rat brain astrocytes studied by multinuclear NMR spectroscopy. J Neurosci Res 1999; 58: 576585.

    • Search Google Scholar
    • Export Citation
  • 53. Redmond HP, Stapleton PP, Neary P, et al. Immunonutrition: the role of taurine. Nutrition 1998; 14: 599604.

  • 54. Huxtable RJ. Physiological actions of taurine. Physiol Rev 1992; 72: 101163.

  • 55. Tomiyasu M, Aida N, Watanabe Y, et al. Monitoring the brain metabolites of children with acute encephalopathy caused by the H1N1 virus responsible for the 2009 influenza pandemic: a quantitative in vivo 1H MR spectroscopy study. Magn Reson Imaging 2012; 30: 15271533.

    • Search Google Scholar
    • Export Citation
  • 56. Wu H, Jin Y, Wei J, et al. Mode of action of taurine as a neuroprotector. Brain Res 2005; 1038: 123131.

  • 57. Panigrahy A, Krieger MD, Gonzalez-Gomez I, et al. Quantitative short echo time 1H-MR spectroscopy of untreated pediatric brain tumors: preoperative diagnosis and characterization. AJNR Am J Neuroradiol 2006; 27: 560572.

    • Search Google Scholar
    • Export Citation
  • 58. Peeling J, Sutherland G. High-resolution 1H NMR spectroscopy studies of extracts of human cerebral neoplasms. Magn Reson Med 1992; 24: 123136.

    • Search Google Scholar
    • Export Citation
  • 59. Kousi E, Tsougos I, Tsolaki E, et al. Spectroscopic evaluation of glioma grading at 3T: the combined role of short and long TE. Scientific World Journal 2012; 2012: 546171.

    • Search Google Scholar
    • Export Citation
  • 60. Rijpkema M, Schuuring J, van der Meulen Y, et al. Characterization of oligodendrogliomas using short echo time 1H MR spectroscopic imaging. NMR Biomed 2003; 16: 1218.

    • Search Google Scholar
    • Export Citation
  • 61. Stoica G, Levine J, Wolff J, et al. Canine astrocytic tumors: a comparative review. Vet Pathol 2011; 48: 266275.

  • 62. Howe FA, Barton SJ, Cudlip SA, et al. Metabolic profiles of human brain tumors using quantitative in vivo 1H magnetic resonance spectroscopy. Magn Reson Med 2003; 49: 223232.

    • Search Google Scholar
    • Export Citation
  • 63. Haga KK, Khor YP, Farrall A, et al. A systematic review of brain metabolite changes, measured with 1H magnetic resonance spectroscopy, in healthy aging. Neurobiol Aging 2009; 30: 353363.

    • Search Google Scholar
    • Export Citation
  • 64. Komoroski RA, Heimberg C, Cardwell D, et al. Effects of gender and region on proton MRS of normal human brain. Magn Reson Imaging 1999; 17: 427433.

    • Search Google Scholar
    • Export Citation
  • 65. Nagae-Poetscher LM, Bonekamp D, Barker PB, et al. Asymmetry and gender effect in functionally lateralized cortical regions: a proton MRS imaging study. J Magn Reson Imaging 2004; 19: 2733.

    • Search Google Scholar
    • Export Citation
  • 66. Devos A, Lukas L, Simonetti AW, et al. Does the combination of magnetic resonance imaging and spectroscopic imaging improve the classification of brain tumours? Conf Proc IEEE Eng Med Biol Soc 2004; 1: 407410.

    • Search Google Scholar
    • Export Citation
  • 67. Julia-Sape M, Coronel I, Majos C, et al. Prospective diagnostic performance evaluation of single-voxel 1H MRS for typing and grading of brain tumours. NMR Biomed 2012; 25: 661673.

    • Search Google Scholar
    • Export Citation
  • 68. Adamo FR, O'Brien RT. Use of cyclosporine to treat granulomatous meningoencephalitis in three dogs. J Am Vet Med Assoc 2004; 225: 12111216.

    • Search Google Scholar
    • Export Citation
  • 69. Granger N, Smith PM, Jeffery ND. Clinical findings and treatment of non-infectious meningoencephalomyelitis in dogs: a systematic review of 457 published cases from 1962 to 2008. Vet J 2010; 184: 290297.

    • Search Google Scholar
    • Export Citation
  • 70. Talarico LR, Schatzberg SJ. Idiopathic granulomatous and necrotising inflammatory disorders of the canine central nervous system: a review and future perspectives. J Small Anim Pract 2010; 51: 138149.

    • Search Google Scholar
    • Export Citation

Advertisement

Evaluation of intracranial neoplasia and noninfectious meningoencephalitis in dogs by use of short echo time, single voxel proton magnetic resonance spectroscopy at 3.0 Tesla

View More View Less
  • 1 Clinic of Diagnostic Imaging, Vetsuisse Faculty, University of Zurich, Winterthurerstrasse 258c, 8057 Zurich, Switzerland.
  • | 2 Clinic of Diagnostic Imaging, Vetsuisse Faculty, University of Zurich, Winterthurerstrasse 258c, 8057 Zurich, Switzerland.
  • | 3 Division of Neurology, Vetsuisse Faculty, University of Zurich, Winterthurerstrasse 258c, 8057 Zurich, Switzerland.
  • | 4 MR Zentrum USZ, Institute for Biomedical Engineering, University and ETH (Swiss Federal Institute of Technology), Zurich, 8092 Zurich, Switzerland.
  • | 5 Clinic of Diagnostic Imaging, Vetsuisse Faculty, University of Zurich, Winterthurerstrasse 258c, 8057 Zurich, Switzerland.
  • | 6 Clinic of Diagnostic Imaging, Vetsuisse Faculty, University of Zurich, Winterthurerstrasse 258c, 8057 Zurich, Switzerland.

Abstract

OBJECTIVE To investigate metabolite concentrations of the brains of dogs with intracranial neoplasia or noninfectious meningoencephalitis by use of short echo time, single voxel proton magnetic resonance spectroscopy (1H MRS) at 3.0 T.

ANIMALS 29 dogs with intracranial lesions (14 with neoplasia [3 oligodendromas, 3 glioblastomas multiformes, 3 astrocytomas, 2 lymphomas, and 3 meningiomas] and 15 is with noninfectious meningoencephalitis) and 10 healthy control dogs.

PROCEDURES Short echo time, single voxel 1H-MRS at 3.0 T was performed on neoplastic and noninfectious inflammatory intracranial lesions identified with conventional MRI. Metabolites of interest included N-acetyl aspartate (NAA), total choline, creatine, myoinositol, the glutamine-glutamate complex (Glx), glutathione, taurine, lactate, and lipids. Data were analyzed with postprocessing fitting algorithm software. Metabolite concentrations relative to brain water content were calculated and compared with results for the healthy control dogs, which had been previously evaluated with the same 1H MRS technique.

RESULTS NAA, creatine, and Glx concentrations were reduced in the brains of dogs with neoplasia and noninfectious meningoencephalitis, whereas choline concentration was increased. Concentrations of these metabolites differed significantly between dogs with neoplasia and dogs with noninfectious meningoencephalitis. Concentrations of NAA, creatine, and Glx were significantly lower in dogs with neoplasia, whereas the concentration of choline was significantly higher in dogs with neoplasia. Lipids were predominantly found in dogs with high-grade intra-axial neoplasia, meningioma, and necrotizing meningoencephalitis. A high concentration of taurine was found in 10 of 15 dogs with noninfectious meningoencephalitis.

CONCLUSIONS AND CLINICAL RELEVANCE 1H MRS provided additional metabolic information about intracranial neoplasia and noninfectious meningoencephalitis in dogs.

Contributor Notes

Address correspondence to Dr. Carrera (icarrera@vetclinics.uzh.ch).